Fresenius

Fresenius News

Fresenius SE Raises Full-Year Guidance to Upper Range After Q3 Organic Growth Beat

Fresenius SE upgraded its fiscal 2026 Core EPS guidance to the upper half of its 10-15% growth range after Q3 delivered 5% organic growth, with the dialysis unit stabilizing and Kabi/Helios divisions contributing positively.

Nov 6, 2026

🇩🇪 Germany

German GP-First Reform Targets Autumn 2026 With Healthcare System Cost Implications

Germany's GP reform targets autumn 2026 rollout, cutting specialist referrals and capping physician fees — key cost implications for healthcare sector investors and insurers.

Aug 2, 2026